Know more... - Pancreatic Cancer India

More documents

Recommendations

Info

Dr Bhawna Sirohi’s CV 2161 An open-label study to find out if ZARNESTRA/R115777 treatment is effective and safe in the treatment of patients with High Risk Myelodysplastic Syndrome (MDS). 2128 A randomised trial of human growth Hormone (hGH) versus placebo in haemato-oncology patients treated intensively for prevention of loss of muscle mass and weight MRS Spectroscopy in new patients with leukaemia 1395 A multiple ascending dose study evaluating the safety and efficacy of intravenous infusion of LF 08-299 administered as first line treatment in combination with corticosteroids in patients with acute GVHD. Fournier. Urology Trials PSMA DNA vaccine in prostate cancer: COREC submission and sponsorship issues AMG 114 trial - Treatment of Anaemia in Subjects with Non-myeloid Malignancies: Local R & D submission Lymphoma /GI 1246: A retrospective and prospective assessment of toxicity and outcome of high dose consolidation chemotherapy in high grade Non-Hodgkin’s lymphoma and Hodgkin’s disease. 2656 A retrospective review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) with or without Rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). 2655 A retrospective study of toxicity and outcome of high dose chemotherapy with autologous stem cell transplant in patients with Hodgkin Lymphoma (HL). 2657 A retrospective study of toxicity and outcome of high dose chemotherapy with autologous stem cell transplant in patients with Non-Hodgkin Lymphoma (NHL). LIFE: Phase III randomsied trial - First-line 5-Fluorouracil Regimens With or Without Oxaliplatin in Advanced Colorectal Cancer Ovarian cancer Impact of second line chemotherapy with a platinum or non-platinum regimen in partially platinum-sensitive and platinum sensitive recurrent epithelial ovarian, fallopian tube and primary peritoneal cancer Breast Cancer ATHENA: International multi-centre trial with the use of bevacizumab and chemotherapy in patients with newly diagnosed metastatic breast cancer. : COREC submission and participation in MREC approval process along with presentation to the Cambridge REC on behalf of the chief investigator Prof Ian Smith. INVITED LECTURES /SESSIONS 1. Spectrum of fungal infections: Marsden experience. EORTC meeting, Nijmegen, Netherlands 14 th October 1998 , 2. Bone Marrow Transplantation -International Youth Science Forum, Bud Flanagan. 3 rd August 1999. 3. “Towards curing Myeloma”; Tata Memorial Hospital, Mumbai 7 th October 1999 4. Myeloma and renal failure –therapeutic implications, SMS Medical College, Jaipur ; 11 th October 1999 20
Dr Bhawna Sirohi’s CV 5. Principles of stem cell transplantation- Indraprastha Apollo Hospital, New Delhi, 14 th October 1999 6. State of art therapy in multiple myeloma – Indian Medical Association, Meerut , 15 th October 1999 7. BMT in Myeloma, Regional Study Day in Haematology on Bone Marrow Transplantation, London, 25 th November 1999. 8. Use of diflucan in Haematological Malignancies, Pfizer global perception meeting, Paris, March 2000 9. Fungal infections in patients with haematological malignancies: RMH experience, National Haematology meeting, Thessaloniki, Greece, 17 th November 2000. 10. Stem cell transplantation in myeloma , Armed Forces Medical college, Pune, December 2000 11. High-dose treatment in Acute Lymphoblastic Leukaemia, 4 th UAE International cancer congress, Abu Dhabi, 30 th January 2001 12. Current Management of Myeloma, 4 th UAE International cancer congress, Abu Dhabi, 30 th January 2001 13. Allogeneic peripheral blood stem cell transplantation, 4 th UAE International cancer congress, Abu Dhabi, 31 st January 2001 14. Allogeneic stem cell transplantation : marrow versus peripheral blood stem cells , Acute Leukaemia Working Party meeting, Sestri Levante, Genoa, 24 th February, 2001 15. International Myeloma Grand round: Case History presentation, Royal Marsden Hospital, London, 14 June 2001. 16. Autologous Transplantation in Myeloma: Marsden experience, Xth Annual course in Haematology, London, 8 th November, 2001 17. Cancer awareness-global scenario. Indian cooperative Oncology Network, Port Blair, India, 12 th January 2002. 18. Erythropoietin and anaemia: Indian cooperative Oncology Network, Port Blair, India, 13 th January 2002. 19. Emerging concepts in Myeloma therapy – APICON, Chennai, India, 16 th January 2002 20. 15 th February 2002 Myeloma and high dose chemotherapy Cripps lecture room RMH 21. Fungal infections in patients with haematological malignancies , Pharmacy Summit, New Orleans , 13 April 2002 22. Review of Amphocil tolerability audit, Pharmacy Summit, New Orleans , 13 April 2002 23. Multiple Myeloma-renal outcomes , South West Thames Renal and Transplant Unit, St Helier’s Hospital, 8 th March 2002 24. Allogeneic stem cell transplantation- current scenario; National CME on Haematopoietic Stem cell Transplantation- 2002, New Delhi, 31 st March 2002 25. Auto transplantation in myeloma: single centre experience: International Myeloma foundation think-tank meeting, US Virgin Islands, St Johns Retreat, 11- 15 May 2002. 26. High-dose treatment in myeloma- is better? ; South Thames Haematology Specialist committee, BMA House, 17 July 2002 27. Growth hormone: Marsden randomised study , Munich, Sept 2002 28. Current place of auto grafting in acute leukaemia ; Regional Study Day for Haematologists , 28 November 2002 21
Page 1 and 2: Dr Bhawna Sirohi’s CV CURRICULUM
Page 3 and 4: Dr Bhawna Sirohi’s CV I joined Gu
Page 5 and 6: Dr Bhawna Sirohi’s CV July 1992-A
Page 7 and 8: Dr Bhawna Sirohi’s CV Editor, Art
Page 9 and 10: Dr Bhawna Sirohi’s CV 1999- 2007:
Page 11 and 12: Dr Bhawna Sirohi’s CV trusts in U
Page 13 and 14: Dr Bhawna Sirohi’s CV 18. Results
Page 15 and 16: Dr Bhawna Sirohi’s CV High Incide
Page 17 and 18: Dr Bhawna Sirohi’s CV 48. Implica
Page 19: Dr Bhawna Sirohi’s CV 2048 A rand
Page 23 and 24: Dr Bhawna Sirohi’s CV 56. Role of
Page 25 and 26: Dr Bhawna Sirohi’s CV 106. Panel
Page 27 and 28: Dr Bhawna Sirohi’s CV 16. Sirohi
Page 29 and 30: Dr Bhawna Sirohi’s CV A, Niederwi
Page 31 and 32: Dr Bhawna Sirohi’s CV 61. Sirohi

Know more... - Pancreatic Cancer India

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?